News & Events

• October 1, 2016
  

  Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase

  Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, et al. Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. 2015;12(1):75–84.

• October 1, 2016
  

  Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project

  Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project. The Lancet Infectious Diseases. 2016 Oct;16(10):1185–92.

• September 29, 2016
  

  The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates

  Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium  Collaborating to Advance Regulatory Science for Neonates.” Pediatric Research 80(4): 462-463 (2016).
• September 20, 2016 - September 23, 2016
  

  C-Path Posters from World Parkinson’s Congress 2016

  In September, Critical Path for Parkinson’s (CPP) participated in the World Parkinson’s Congress in Portland, Oregon. This meeting brought together people living with Parkinson’s disease (PD), their care partners, and leading researchers, to learn of current advances in PD research and therapies. The 2016 conference saw 4,555 registrants from 67 countries: 40% neuroscientists, clinicians, researchers,...
• September 16, 2016
  

  Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories

  Kim K, Chini N, Fairchild DG, Engle SK, Reagan WJ, Summers SD, Mirsalis JC, Cardiac Hypertrophy Working Group of the Predictive Safety Testing Consortium. Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories. Toxicologic Pathology. 2016 Sep 16.